Norlase
PrivateLast Round
Debt
Feb 27, 2025
Est. Valuation
$60M
Total Funding Raised
$14.07M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Norlase operates in Healthcare & Life Sciences and is based in Ballerup. Its latest recorded funding round was a VC Round in May 2023.
Norlase is a medical device company that develops and manufactures next-generation laser solutions for the treatment of retina and glaucoma diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Norlase Comparables
Compare Norlase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OD-OS GmbH | 81% | |
| Lumibird | 80% | |
| IRIDEX Corporation | 78% |
For institutional investors. Book with your work email.
Norlase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 27, 2025 | ||||
| VC Round | May 23, 2023 | ||||
| Series B | Oct 25, 2021 | ||||
| Series A | Mar 1, 2019 | ||||
| Grant | Dec 17, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Norlase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Investment Bank Group | Debt |
| West Hill Capital | Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 34% MoM, reaching 10.7K.
- May 16, 2026
Monthly visitors increased 88% MoM, reaching 16.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 8, 2026
Norlase plans to showcase its Lynx Pattern LIO and Echo Pattern Laser at ESCRS 2026 in the United Kingdom in 2026.
- hiresSep 8, 2026
Norlase appoints Heather Robbins as National Sales Director, UK, to lead private-sector operations as it transitions to a hybrid sales and support model in the United Kingdom on Sep 8th '26.
- attends_eventSep 8, 2026
Norlase is set to join the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in the United Kingdom on Sep 11th-15th '26, where it showcases its Lynx Pattern LIO and Echo Pattern Laser and hosts educational presentations.
- launchesSep 8, 2026
At the ESCRS meeting in the United Kingdom in Sep '26, Norlase is set to showcase Lynx Pattern LIO and Echo Pattern Laser and host educational presentations on pattern laser trabeculoplasty and vitreoretinal examination before cataract surgery.
For institutional investors. Book with your work email.
Norlase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Norlase's valuation, stock price, and market status.
Is Norlase a public or private company?
Norlase is a private company.
What is the current stock price of Norlase?
Norlase is a private company, so its shares have no public market price. Caplight tracks Norlase's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Norlase worth (valuation)?
Norlase's valuation is estimated at $60.0M based on funding round data.
Can I buy Norlase stock?
Norlase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Norlase's last funding round?
Norlase's most recent funding round was Debt on February 27, 2025.
Who are the main investors in Norlase?
Key investors in Norlase include West Hill Capital.
Will Norlase IPO soon?
No public IPO plans have been announced for Norlase.
How can I track Norlase secondary market activity?
Caplight tracks bids, offers, and trades in Norlase's shares on secondary markets.